Bladder cancer updates from the second half of 2024

EMUC 2024: Optimising strategies in mHSPC and mCRPC

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer

New classification for identifying HR myeloma based on cytogenetic abnormalities

Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan

Tele-mentoring: Impact of project ECHO

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Choosing the right patients for transplant

Choosing Wisely in endometrial & cervix cancers: Medical therapy

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Cancer mutation prediction using artificial intelligence

ESMO 2024: Optimising the personalisation of prostate cancer treatment